
British investor backs rescue of failing genetics firm 23andMe
A British investor and one of the largest shareholders in 23andMe is interested in backing a rescue of the troubled Californian consumer genetics company. Richard Magides, the director of Zentree Investment, a Singapore-based investor, had been building a …